» Articles » PMID: 12151518

The Slow Axonal Transport of the Microtubule-associated Protein Tau and the Transport Rates of Different Isoforms and Mutants in Cultured Neurons

Overview
Journal J Neurosci
Specialty Neurology
Date 2002 Aug 2
PMID 12151518
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

We demonstrate that the microtubule-associated protein tau, in the form of enhanced green fluorescent protein (EGFP) tau, is transported along axons of neurons in culture in the slow component of axonal transport with a speed comparable with that previously measured in vivo. It was demonstrated that the EGFP tag has no effect on transport characteristics, and the methodology enables slow transport rates of individual tau isoforms and tau mutants to be measured. We also expressed EGFP-tagged tau isoforms containing either three or four C-terminal repeats and zero or two N-terminal inserts in cultured neurons. No significant differences were found in the average rate of slow transport of the wild-type tau isoforms, suggesting that the exon 10 C-terminal repeat or the N-terminal inserts do not contain regions that play a significant regulatory role in axonal transport. Similarly, we found that missense mutations in tau have no noticeable effect on the rate of transport; hence their ability to cause neurodegeneration is by another mechanism other than that affecting the overall slow axonal transport of tau.

Citing Articles

Axodendritic targeting of TAU and MAP2 and microtubule polarization in iPSC-derived versus SH-SY5Y-derived human neurons.

Breuer H, Bell-Simons M, Zempel H Open Life Sci. 2025; 19(1):20221010.

PMID: 39759106 PMC: 11699562. DOI: 10.1515/biol-2022-1010.


A review of proposed mechanisms for neurodegenerative disease.

Kelser B, Teichner E, Subtirelu R, Hoss K Front Aging Neurosci. 2024; 16:1370580.

PMID: 39439710 PMC: 11493710. DOI: 10.3389/fnagi.2024.1370580.


EphB1 controls long-range cortical axon guidance through a cell non-autonomous role in GABAergic cells.

Assali A, Chenaux G, Cho J, Berto S, Ehrlich N, Cowan C Development. 2024; 151(5).

PMID: 38345254 PMC: 10946438. DOI: 10.1242/dev.201439.


Insights into T-cell dysfunction in Alzheimer's disease.

Dai L, Shen Y Aging Cell. 2021; 20(12):e13511.

PMID: 34725916 PMC: 8672785. DOI: 10.1111/acel.13511.


Protective effects of a small molecule inhibitor ligand against hyperphosphorylated tau-induced mitochondrial and synaptic toxicities in Alzheimer disease.

Pradeepkiran J, Munikumar M, Reddy A, Reddy P Hum Mol Genet. 2021; 31(2):244-261.

PMID: 34432046 PMC: 8743003. DOI: 10.1093/hmg/ddab244.


References
1.
Dayanandan R, van Slegtenhorst M, Mack T, Ko L, Yen S, Leroy K . Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation. FEBS Lett. 1999; 446(2-3):228-32. DOI: 10.1016/s0014-5793(99)00222-7. View

2.
Williamson T, Cleveland D . Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci. 1999; 2(1):50-6. DOI: 10.1038/4553. View

3.
Nacharaju P, Lewis J, Easson C, Yen S, Hackett J, Hutton M . Accelerated filament formation from tau protein with specific FTDP-17 missense mutations. FEBS Lett. 1999; 447(2-3):195-9. DOI: 10.1016/s0014-5793(99)00294-x. View

4.
Torroja L, Chu H, Kotovsky I, White K . Neuronal overexpression of APPL, the Drosophila homologue of the amyloid precursor protein (APP), disrupts axonal transport. Curr Biol. 1999; 9(9):489-92. DOI: 10.1016/s0960-9822(99)80215-2. View

5.
Goedert M, Jakes R, Crowther R . Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments. FEBS Lett. 1999; 450(3):306-11. DOI: 10.1016/s0014-5793(99)00508-6. View